Re-Examining the Role of TNF in MS Pathogenesis and Therapy.

TNF therapy TNFR1 TNFR2 Theiler’s murine encephalomyelitis virus cuprizone demyelination experimental autoimmune encephalomyelitis neurodegeneration synaptic damage

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
14 10 2020
Historique:
received: 21 09 2020
revised: 10 10 2020
accepted: 12 10 2020
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 7 4 2021
Statut: epublish

Résumé

Multiple sclerosis (MS) is a common neurological disorder of putative autoimmune origin. Clinical and experimental studies delineate abnormal expression of specific cytokines over the course of the disease. One major cytokine that has been shown to play a pivotal role in MS is tumor necrosis factor (TNF). TNF is a pleiotropic cytokine regulating many physiological and pathological functions of both the immune system and the central nervous system (CNS). Convincing evidence from studies in human and experimental MS have demonstrated the involvement of TNF in various pathological hallmarks of MS, including immune dysregulation, demyelination, synaptopathy and neuroinflammation. However, due to the complexity of TNF signaling, which includes two-ligands (soluble and transmembrane TNF) and two receptors, namely TNF receptor type-1 (TNFR1) and type-2 (TNFR2), and due to its cell- and context-differential expression, targeting the TNF system in MS is an ongoing challenge. This review summarizes the evidence on the pathophysiological role of TNF in MS and in different MS animal models, with a special focus on pharmacological treatment aimed at controlling the dysregulated TNF signaling in this neurological disorder.

Identifiants

pubmed: 33066433
pii: cells9102290
doi: 10.3390/cells9102290
pmc: PMC7602209
pii:
doi:

Substances chimiques

Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Neuroimmunol. 1996 May;66(1-2):115-23
pubmed: 8964905
J Neuroimmunol. 1997 Feb;72(2):163-8
pubmed: 9042109
Nature. 2012 Aug 23;488(7412):508-511
pubmed: 22801493
Brain. 1996 Feb;119 ( Pt 1):213-23
pubmed: 8624683
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13051-13056
pubmed: 30498033
Int J Biochem Cell Biol. 1997 Jun;29(6):867-70
pubmed: 9304801
Mult Scler. 2009 Jan;15(1):120-3
pubmed: 18755820
Neurobiol Aging. 2007 Apr;28(4):533-6
pubmed: 16569464
Glia. 2006 Apr 1;53(5):529-37
pubmed: 16374777
Neurology. 2001 Nov 27;57(10):1885-8
pubmed: 11723281
Neuron. 2009 Oct 15;64(1):93-109
pubmed: 19840552
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9292-6
pubmed: 1718003
J Exp Med. 1998 May 4;187(9):1517-28
pubmed: 9565643
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11294-8
pubmed: 7479982
Neuron. 2008 Mar 27;57(6):819-26
pubmed: 18367083
Cell Death Differ. 2003 Jan;10(1):45-65
pubmed: 12655295
Immunity. 1995 Jun;2(6):561-72
pubmed: 7540941
J Exp Med. 1989 Aug 1;170(2):607-12
pubmed: 2754393
J Neuroimmunol. 2011 Jun;235(1-2):1-8
pubmed: 21565409
Eur J Immunol. 2011 Jul;41(7):2010-20
pubmed: 21491419
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319
J Neuroinflammation. 2019 Dec 7;16(1):259
pubmed: 31810488
Int Immunol. 1990;2(6):539-44
pubmed: 1707660
Microbiol Spectr. 2016 Aug;4(4):
pubmed: 27726761
Nat Immunol. 2010 Jan;11(1):7-13
pubmed: 20016504
Neuron. 1996 Mar;16(3):675-86
pubmed: 8785064
Nat Rev Immunol. 2009 Apr;9(4):271-85
pubmed: 19319144
Mediators Inflamm. 2014;2014:861231
pubmed: 24966471
Ann Neurol. 2020 May 17;:
pubmed: 32418239
Cells. 2019 Feb 20;8(2):
pubmed: 30791579
Cell. 2015 Dec 17;163(7):1730-41
pubmed: 26686654
Front Immunol. 2018 Apr 19;9:784
pubmed: 29725328
Am J Pathol. 1998 Sep;153(3):801-13
pubmed: 9736029
Nat Rev Immunol. 2015 Sep 15;15(9):545-58
pubmed: 26250739
Clin Exp Immunol. 2014 Jan;175(1):41-8
pubmed: 24111507
Immunity. 2001 Oct;15(4):533-43
pubmed: 11672536
Neurology. 1999 Aug 11;53(3):457-65
pubmed: 10449104
Nature. 2006 Apr 20;440(7087):1054-9
pubmed: 16547515
Nervenarzt. 2000 Aug;71(8):597-610
pubmed: 10996910
Ann Neurol. 1995 Apr;37(4):424-35
pubmed: 7536402
Cytokine. 2018 Nov;111:454-459
pubmed: 29885993
Front Cell Neurosci. 2020 Jul 07;14:190
pubmed: 32733206
J Clin Invest. 2013 Feb;123(2):928-32
pubmed: 23348744
Eur J Immunol. 1997 Apr;27(4):963-70
pubmed: 9130651
Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 2):S11-7
pubmed: 1370262
Arthritis Rheum. 2001 Dec;44(12):2862-9
pubmed: 11762947
J Neural Transm (Vienna). 2014 Aug;121(8):945-55
pubmed: 24633998
J Chiropr Med. 2016 Sep;15(3):190-6
pubmed: 27660595
Cell. 2006 May 19;125(4):785-99
pubmed: 16713568
Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):901-21
pubmed: 23917093
Int Immunol. 1996 Jul;8(7):1001-8
pubmed: 8757945
Brain. 2011 Sep;134(Pt 9):2736-54
pubmed: 21908877
J Leukoc Biol. 2003 Oct;74(4):572-82
pubmed: 12960285
J Neurol. 2005 Nov;252 Suppl 5:v3-9
pubmed: 16254699
Nat Immunol. 2005 Apr;6(4):345-52
pubmed: 15785760
Neurol Res. 2018 Mar;40(3):153-159
pubmed: 29297273
FEBS Lett. 2011 Dec 1;585(23):3611-8
pubmed: 21513711
Exp Neurol. 2002 Apr;174(2):193-200
pubmed: 11922661
Cell. 1995 Dec 1;83(5):793-802
pubmed: 8521496
J Immunol. 2013 Feb 1;190(3):1076-84
pubmed: 23277487
J Biol Chem. 2004 Jul 30;279(31):32869-81
pubmed: 15155767
Pharmacol Ther. 2008 Feb;117(2):244-79
pubmed: 18155297
Front Cell Neurosci. 2014 Nov 03;8:362
pubmed: 25404894
J Immunol. 1993 Nov 1;151(9):4637-41
pubmed: 8409424
Nat Rev Neurosci. 2015 Mar;16(3):147-58
pubmed: 25697158
Ther Adv Neurol Disord. 2020 Jan 2;13:1756286419895155
pubmed: 31921355
J Immunol. 2007 Jul 1;179(1):154-61
pubmed: 17579033
Brain. 2006 Aug;129(Pt 8):1953-71
pubmed: 16632554
J Immunol. 2006 Jan 15;176(2):721-5
pubmed: 16393953
J Neurosci. 2008 May 14;28(20):5189-94
pubmed: 18480275
J Neuroimmunol. 2001 Jan 1;112(1-2):197-205
pubmed: 11108949
Curr Neurol Neurosci Rep. 2017 Apr;17(4):36
pubmed: 28337644
J Exp Med. 2001 Feb 19;193(4):427-34
pubmed: 11181695
Eur J Immunol. 1999 Mar;29(3):774-80
pubmed: 10092079
Neurobiol Dis. 2001 Aug;8(4):590-9
pubmed: 11493024
Immunol Allergy Clin North Am. 2009 May;29(2):223-8
pubmed: 19389578
Neuron. 2011 Mar 10;69(5):988-1001
pubmed: 21382557
J Virol. 1991 Dec;65(12):6612-20
pubmed: 1658365
Curr Opin Neurol. 2018 Dec;31(6):752-759
pubmed: 30300239
JCI Insight. 2017 Apr 20;2(8):
pubmed: 28422748
Immunol Rev. 1999 Jun;169:175-94
pubmed: 10450517
Brain. 2011 Sep;134(Pt 9):2722-35
pubmed: 21908876
Glia. 2005 Jan 1;49(1):1-14
pubmed: 15382206
Front Immunol. 2019 Dec 17;10:2901
pubmed: 31921162
Cytokine. 2002 Oct 21;20(2):86-9
pubmed: 12445803
Trends Neurosci. 2012 Oct;35(10):638-47
pubmed: 22749718
J Exp Med. 1996 Oct 1;184(4):1397-411
pubmed: 8879212
J Neuroimmunol. 1991 Dec;35(1-3):285-93
pubmed: 1955570
Brain Behav Immun. 2020 Feb;84:132-146
pubmed: 31785393
J Neurosci. 2009 Mar 18;29(11):3442-52
pubmed: 19295150
Mol Neurobiol. 2017 May;54(4):2950-2960
pubmed: 27023227
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5656-61
pubmed: 17372191
Cell Death Differ. 2010 Jul;17(7):1083-91
pubmed: 19927157
Cytokine. 2015 Dec;76(2):527-536
pubmed: 26321413
J Immunol. 2006 Sep 15;177(6):4196-202
pubmed: 16951385
Vaccine. 2011 Apr 12;29(17):3356-62
pubmed: 20850537
Adv Exp Med Biol. 1999;468:245-59
pubmed: 10635034
J Neurol. 2006 Jun;253(6):701-6
pubmed: 16511637
J Control Release. 2011 Jan 5;149(1):8-14
pubmed: 20036293
Int Immunol. 2015 Jan;27(1):55-62
pubmed: 25411043
Front Immunol. 2018 Mar 26;9:594
pubmed: 29632537
Eur J Immunol. 1999 Feb;29(2):626-32
pubmed: 10064079
Isr J Med Sci. 1992 Feb;28(2):126-30
pubmed: 1313788
Virology. 2010 Jun 20;402(1):102-11
pubmed: 20381109
Expert Opin Pharmacother. 2004 Mar;5(3):581-94
pubmed: 15013927
Front Cell Neurosci. 2014 Mar 13;8:73
pubmed: 24659953
Mult Scler. 2010 Sep;16(9):1044-55
pubmed: 20685763
J Neuroinflammation. 2016 Feb 22;13:46
pubmed: 26906225
J Immunol. 2015 Feb 1;194(3):999-1010
pubmed: 25548233
Ann Neurol. 2018 Apr;83(4):739-755
pubmed: 29518260
Cereb Cortex. 2004 Jan;14(1):97-105
pubmed: 14654461
Front Pharmacol. 2019 Mar 22;10:286
pubmed: 30967783
Eur J Immunol. 2011 Feb;41(2):335-44
pubmed: 21268004
J Neurochem. 1998 May;70(5):1876-86
pubmed: 9572271
Nat Rev Neurol. 2015 Dec;11(12):711-24
pubmed: 26585978
N Engl J Med. 1991 Aug 15;325(7):467-72
pubmed: 1852181
Autoimmunity. 2004 Sep-Nov;37(6-7):465-71
pubmed: 15621573
Cell. 1993 May 7;73(3):457-67
pubmed: 8387893
Nat Rev Rheumatol. 2016 Jan;12(1):49-62
pubmed: 26656660
Biochem Pharmacol. 2000 Jan 1;59(1):13-23
pubmed: 10605930
Mult Scler. 2014 Mar;20(3):304-12
pubmed: 23886826
Einstein (Sao Paulo). 2017 Jan-Mar;15(1):100-104
pubmed: 28444098
Lancet Neurol. 2014 Aug;13(8):807-22
pubmed: 25008549
Arch Neurol. 2003 Aug;60(8):1082-8
pubmed: 12925363
Ann Neurol. 2015 Jul;78(1):3-20
pubmed: 25808056
Neurology. 1996 Dec;47(6):1531-4
pubmed: 8960740
J Neuroimmunol. 1997 May;75(1-2):104-12
pubmed: 9143243
Ann Neurol. 2006 Jul;60(1):12-21
pubmed: 16802293
Arch Physiol Biochem. 2001 Oct;109(4):350-3
pubmed: 11935370
J Clin Invest. 1991 Mar;87(3):949-54
pubmed: 1999503
J Immunol. 2011 Dec 1;187(11):5660-70
pubmed: 22058414
Nat Med. 1998 Jan;4(1):78-83
pubmed: 9427610
Brain Res. 2005 Feb 9;1034(1-2):11-24
pubmed: 15713255
Neurology. 2003 Oct 28;61(8):1113-20
pubmed: 14581674
Exp Neurol. 2012 Oct;237(2):296-303
pubmed: 22836148
Neurology. 2013 May 28;80(22):2010-6
pubmed: 23624563
J Immunol. 2010 Jun 15;184(12):6891-900
pubmed: 20488789
Mult Scler. 2001 Jun;7(3):145-50
pubmed: 11475436
Cytokine Growth Factor Rev. 2014 Aug;25(4):453-72
pubmed: 25169849
Sci Rep. 2018 Sep 11;8(1):13628
pubmed: 30206422
Science. 2002 Mar 22;295(5563):2282-5
pubmed: 11910117
Blood. 2006 Jul 1;108(1):253-61
pubmed: 16537805
Semin Immunol. 2014 Jun;26(3):253-66
pubmed: 24958609
Brain Behav Immun. 2019 Oct;81:247-259
pubmed: 31220564
Br J Pharmacol. 2011 Oct;164(4):1079-106
pubmed: 21371012
J Immunol. 1991 Dec 15;147(12):4229-38
pubmed: 1661312
Sci Rep. 2017 Oct 20;7(1):13646
pubmed: 29057962
J Immunol. 1998 Oct 15;161(8):4437-46
pubmed: 9780223
Neurology. 2013 Nov 26;81(22):1891-9
pubmed: 24174586
Neuron Glia Biol. 2004 Aug;1(3):263-73
pubmed: 16520832
J Neural Transm Suppl. 2000;(60):277-90
pubmed: 11205147
J Exp Med. 2000 Mar 6;191(5):813-22
pubmed: 10704463
J Neurosci. 2016 May 4;36(18):5128-43
pubmed: 27147664
Cell Rep. 2015 Mar 24;10(11):1836-49
pubmed: 25801023
Eur J Clin Invest. 1997 Dec;27(12):1038-43
pubmed: 9466133
J Exp Med. 2020 May 4;217(5):
pubmed: 32078678
Lancet. 1994 Oct 22;344(8930):1105-10
pubmed: 7934491
Neuropathol Appl Neurobiol. 2020 Feb;46(2):160-170
pubmed: 31125471
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
Tissue Barriers. 2015 Apr 03;3(1-2):e978720
pubmed: 25838983
Cell Rep. 2017 Jan 3;18(1):198-212
pubmed: 28052249
Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S134-40
pubmed: 15552527
J Exp Med. 2002 Aug 5;196(3):379-87
pubmed: 12163566
J Immunol. 1995 Jul 15;155(2):947-57
pubmed: 7608570
J Neurotrauma. 2010 Jan;27(1):287-92
pubmed: 19811092
Inflamm Res. 2019 Dec;68(12):1049-1059
pubmed: 31559449
Lancet Neurol. 2019 Feb;18(2):185-197
pubmed: 30663608
Physiol Rev. 2019 Jan 1;99(1):115-160
pubmed: 30354964
Eur J Immunol. 2012 Feb;42(2):403-12
pubmed: 22105853
Trends Neurosci. 2009 Aug;32(8):421-31
pubmed: 19615761
Sci Transl Med. 2015 Jun 10;7(291):291ra93
pubmed: 26062845
Eur J Immunol. 1997 Aug;27(8):1973-81
pubmed: 9295034
JCI Insight. 2019 Dec 19;4(24):
pubmed: 31852844
J Autoimmun. 2016 Sep;73:100-10
pubmed: 27396526
Neuron. 1988 Oct;1(8):623-34
pubmed: 2908446
Rev Neurol (Paris). 1998 Sep;154(8-9):577-85
pubmed: 9809372
Neurosci Lett. 1994 May 19;172(1-2):151-4
pubmed: 8084523
Front Immunol. 2018 Apr 30;9:925
pubmed: 29760711
Ann Neurol. 2001 Aug;50(2):169-80
pubmed: 11506399
J Immunol. 2000 Nov 1;165(9):5304-14
pubmed: 11046065
J Clin Invest. 2010 Dec;120(12):4558-68
pubmed: 21099113
Clin Exp Immunol. 2003 Feb;131(2):324-34
pubmed: 12562396
Cytokine. 1993 Nov;5(6):583-8
pubmed: 8186370
Front Immunol. 2018 Mar 22;9:583
pubmed: 29623079
Neuroscience. 2015 Aug 27;302:2-22
pubmed: 26117714
Nat Neurosci. 2001 Nov;4(11):1116-22
pubmed: 11600888
Neurosci Lett. 1991 Aug 19;129(2):318-20
pubmed: 1745413
Cytokine. 2018 Jan;101:14-18
pubmed: 27531077
Mult Scler. 2001 Jun;7(3):151-6
pubmed: 11475437
Eur J Immunol. 1988 Aug;18(8):1303-6
pubmed: 3262066
Neurochem Res. 2002 Nov;27(11):1535-42
pubmed: 12512958
Cell. 1986 Jun 6;45(5):659-66
pubmed: 2871942
Mol Med Rep. 2013 Mar;7(3):1010-20
pubmed: 23292766
Front Cell Dev Biol. 2020 May 26;8:401
pubmed: 32528961
Microsc Res Tech. 2000 Aug 1;50(3):184-95
pubmed: 10891884
J Neural Transm (Vienna). 2010 Feb;117(2):165-9
pubmed: 19946712
J Neurol Sci. 1997 Nov 6;152(1):51-61
pubmed: 9395126
Cell Immunol. 2000 Oct 10;205(1):24-33
pubmed: 11078604
Clin Exp Immunol. 2011 Dec;166(3):338-45
pubmed: 22059991
Eur J Immunol. 2006 Oct;36(10):2768-80
pubmed: 16983719

Auteurs

Diego Fresegna (D)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.

Silvia Bullitta (S)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Alessandra Musella (A)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Department of Human Sciences and Quality of Life Promotion, University of Rome San Raffaele, 00166 Roma, Italy.

Francesca Romana Rizzo (FR)

Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Francesca De Vito (F)

Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.

Livia Guadalupi (L)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Silvia Caioli (S)

Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.

Sara Balletta (S)

Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Krizia Sanna (K)

Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Ettore Dolcetti (E)

Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Valentina Vanni (V)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Antonio Bruno (A)

Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.

Fabio Buttari (F)

Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.

Mario Stampanoni Bassi (M)

Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.

Georgia Mandolesi (G)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Department of Human Sciences and Quality of Life Promotion, University of Rome San Raffaele, 00166 Roma, Italy.

Diego Centonze (D)

Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.
Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.

Antonietta Gentile (A)

Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH